Shelter Pharma converts 465,000 warrants for Rs. 14,734,687.50
FUNDRAISE
▲ Positive Development
LOW RISK
📅 Filed on BSE: 16 Oct 2026, 03:15 PM IST · BSE ID: 51842870-3b30-4ab8-864b-d57df7f42711
View Original BSE Filing (PDF)
💡
In Simple Terms
Shelter Pharma turned 465,000 warrant options into real shares, bringing in over Rs. 1.47 Crore.
🤖 AI Summary
- Shelter Pharma converted 465,000 warrants into equity shares, raising Rs. 14,734,687.50.
- The conversion was approved by the Board of Directors on October 16, 2026.
- New equity shares issued rank pari-passu with existing shares.
- Company's paid-up share capital increased to Rs. 173,017,920/-.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Warrants converted
465000
Total Amount Paid for Conversion
Rs. 14,734,687.50
Face Value per Equity Share
Rs. 10/-
Issue Price per Warrant
Rs. 42.25/-
Remaining Exercise Price per Share
Rs. 31.6875/-
Old Paid-up Equity Share Capital
Rs. 168,367,920/-
New Paid-up Equity Share Capital
Rs. 173,017,920/-
🏢 How This Affects the Company
The conversion of warrants has increased the company's paid-up equity share capital by Rs. 4,650,000/-, reflecting an inflow of Rs. 14,734,687.50.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders in response to this filing.
👤
Who Is Affected
Shareholders are affected by the increase in the total number of equity shares, impacting potential future earnings per share dilution. Paid-up capital increased by Rs. 4,650,000/-.
🔍
Management Signal
This action signals management's intent to capitalize on previously issued warrants, thereby strengthening the company's equity structure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
BSE listing approval for new equity shares.
Quarterly results for FY27 to assess impact on EPS.
Company's future capital raising plans.
LOW RISK
Routine capital infusion event, no new risks identified in filing.
💡 Investor Takeaway
Shelter Pharma converted 465,000 warrants into equity shares, raising Rs. 14,734,687.50. Paid-up capital increased from Rs. 168,367,920/- to Rs. 173,017,920/-.
⚖️ Strengths & Concerns
✅ Positives
- Successfully completed conversion of 465,000 warrants into equity shares.
- Raised Rs. 14,734,687.50 through warrant conversion, enhancing share capital.
📅 Company Track Record
Shelter Pharma previously completed conversion of 114,000 warrants in May 2026, raising Rs. 36,12,375/-. The company had initially allotted 88,08,000 warrants in July 2025.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
How many warrants did Shelter Pharma convert into equity shares?
Shelter Pharma converted 465,000 warrants into 465,000 equity shares.
How much capital did Shelter Pharma raise from this warrant conversion?
The company raised Rs. 14,734,687.50 from the conversion of these warrants.
What is the new paid-up equity share capital of Shelter Pharma after conversion?
The paid-up equity share capital increased to Rs. 173,017,920/- from Rs. 168,367,920/-.
What was the issue price per warrant for Shelter Pharma?
The issue price per warrant was Rs. 42.25/-.
Questions based on this BSE filing only. For information purposes.